Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cloud computing In Pharmaceutical Market Size, Value And Growth Trends Through 2030
The market size for cloud computing in pharmaceutical has experienced swift expansion in recent years. This market is projected to climb from $12.93 billion in 2025 to $15.07 billion by 2026, at a compound annual growth rate (CAGR) of 16.6%. Historically, this growth has been fueled by factors including the increasing adoption of digital data management, a growing necessity for scalable information technology (IT) infrastructure, the rising deployment of cloud for clinical data storage, the expansion of pharmaceutical research and development (R&D) activities, and an increasing focus on cost-efficient computing systems.
The cloud computing in pharmaceutical market is projected to experience substantial expansion in the coming years. By 2030, its valuation is anticipated to reach $27.60 billion, exhibiting a compound annual growth rate (CAGR) of 16.3%. This forecasted growth is driven by several factors, including the increasing demand for AI-enabled drug discovery, the rising acceptance of hybrid cloud models, a growing transition towards digital pharma manufacturing, the expanded use of real-world data and analytics, and the increasing necessity for secure cloud-based compliance systems. Key trends shaping this period encompass progress in AI and machine learning platforms, evolution in cloud-based clinical trial technologies, breakthroughs in blockchain-enabled data security, ongoing research and development into automated pharmaceutical workflows, and enhancements in big data analytics for drug development.
Download A Free Sample Report For Comprehensive Market Insights:
Cloud computing In Pharmaceutical Market Opportunity Drivers: What Is Creating New Revenue Potential?
The increasing demand for personalized medicine is anticipated to drive the expansion of the cloud computing in pharmaceutical market in the foreseeable future. Personalized medicine is a healthcare strategy focused on adapting treatments to individual patients based on their genetic, environmental, and lifestyle attributes to achieve optimal results and enhance care. The need for personalized medicine is on the rise, driven by progress in genomic technologies that allow for accurate identification of genetic variations and the creation of customized treatments for individuals. Cloud computing in the pharmaceutical sector aids personalized medicine by enabling scalable storage and processing of extensive patient, genomic, and clinical data. It enhances treatment accuracy and accelerates development by supporting advanced analytics, real-time collaboration, and data-driven drug discovery specifically tailored to individual patient profiles. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, marking a substantial increase from the 12 approved in 2022. Consequently, the growing demand for personalized medicine is a key driver for the growth of the cloud computing in pharmaceutical market.
Cloud computing In Pharmaceutical Market Segment Analysis: What Are The Major Market Categories?
The cloud computing in pharmaceutical market covered in this report is segmented –
1) By Service Model: Infrastructure As A Service (IaaS), Platform As A Service (PaaS), Software As A Service (SaaS)
2) By Deployment Type: Public Cloud, Private Cloud, Hybrid Cloud
3) By Technology Type: Artificial Intelligence (AI) And Machine Learning, Big Data Analytics, Internet Of Things (IoT), Blockchain, Data Backup And Disaster Recovery Solutions
4) By Application Area: Drug Discovery And Development, Clinical Trials Management, Manufacturing And Supply Chain, Regulatory Compliance, Pharmacovigilance
5) By End User: Pharmaceutical Companies, Biotechnology Firms, Research Organizations, Contract Research Organizations (CROs), Academic Institutions
Subsegments:
1) By Infrastructure As A Service: Virtual Machines, Storage Services, Networking Services, Backup Services, Disaster Recovery
2) By Platform As A Service: Application Hosting, Database Management, Development Tools, Middleware Services, Integration Services
3) By Software As A Service: Clinical Data Management Software, Regulatory Compliance Software, Supply Chain Management Software, Collaboration Tools, Analytics Software
Cloud computing In Pharmaceutical Market Innovation Trends Driving Future Development
Major companies operating in the cloud computing in pharmaceutical market are concentrating on developing advanced platforms, such as unifying systems, to enhance data protection, regulatory compliance, and operational efficiency across scientific software environments. A unifying platform refers to a singular, integrated system that brings together multiple tools, functions, or services into one cohesive interface. For instance, in April 2024, Certara Inc., a US-based provider of model-informed drug development software, launched Certara Cloud. This integrating platform incorporates the company’s extensive suite of scientific software solutions, allowing customers to access and manage their licensed products from discovery to submission using a single login ID, consequently enhancing user experience and accelerating time-to-insight for novel therapeutic programs. This cloud platform aims to further unify its end-to-end scientific software ecosystem, featuring centralized security and IT administration. By embedding centralized security controls into its cloud platform, Certara strengthens data integrity, simplifies regulatory adherence, and supports secure collaboration across the entire drug development lifecycle, spanning from early research through regulatory submission.
Cloud computing In Pharmaceutical Market Leading Companies Driving Competitive Growth
Major companies operating in the cloud computing in pharmaceutical market are Amazon Web Services Inc., Google LLC, Microsoft Corporation, Alibaba Group Holding Ltd., Dell Technologies Inc., Tencent Holdings Ltd., Accenture plc, International Business Machines Corporation, Cisco Systems Inc., Oracle Corporation, Salesforce Inc., SAP SE, Hewlett Packard Enterprise Company, Capgemini SE, Cognizant Technology Solutions Corporation, DXC Technology Company, Akamai Technologies Inc., Snowflake Inc., CareCloud Inc., ClearDATA Networks Inc.
Access The Complete Cloud computing In Pharmaceutical Market Report:
#Cloud computing In Pharmaceutical Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the cloud computing in pharmaceutical market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cloud computing in pharmaceutical market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.